Pfizer, Allergan won’t comment on US tax reform
MLex Summary: Drugmakers Pfizer and Allergan have said they won’t comment on how the US Treasury’s tax reform could affect their planned merger.The statement follows....To view the full article, register now.
Already a subscriber? Click here to view full article